Researcher.Life Logo

Endokrynologia Polska : Impact Factor & More

eISSN: 2299-8306pISSN: 0423-104X
JournalOpen Access

Key Metrics

CiteScore
2.5
Impact Factor
< 5
SJR
Q3Medicine (all)
SNIP
0.62
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Endokrynologia Polska

Endokrynologia Polska Journal Specifications

Overview
Publisher VIA MEDICA
Language English,Polish
Frequency Bi-monthly
Article Processing ChargesEUR 500
Publication Time20
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish,Polish
Society/Institute/SponsorPolish Society of Endocrinology
FrequencyBi-monthly
Publication Start Year1949
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 20
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Endokrynologia Polska ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Endokrynologia Polska

Gut microbiome Lactobacillus acidophilus and its relationship with thyroid nodules and thyroid hormonal profile.
  • 9 Oct 2025
  • Endokrynologia Polska
Long-term recombinant human growth hormone therapy in Dent's disease type 1.
  • 9 Oct 2025
  • Endokrynologia Polska
Lnc-MPEG1-1 promotes papillary thyroid carcinoma progression through association with BRAF mutations.
  • 9 Oct 2025
  • Endokrynologia Polska
Controlled attenuation parameter is associated with metabolic disorders in patients with obesity in the Chinese population.
  • 9 Oct 2025
  • Endokrynologia Polska
Can the treatment of glaucoma cause metabolic acidosis in a person with type 1 diabetes?
  • 9 Oct 2025
  • Endokrynologia Polska
Non-hypoglycemic insulin autoimmune syndrome complicated with T2DM after using lipoic acid.
  • 9 Oct 2025
  • Endokrynologia Polska
Gut microbiome Lactobacillus acidophilus and its relationship with thyroid nodules and thyroid hormonal profile.
  • 9 Oct 2025
  • Endokrynologia Polska
Long-term recombinant human growth hormone therapy in Dent's disease type 1.
  • 9 Oct 2025
  • Endokrynologia Polska
Lnc-MPEG1-1 promotes papillary thyroid carcinoma progression through association with BRAF mutations.
  • 9 Oct 2025
  • Endokrynologia Polska
Controlled attenuation parameter is associated with metabolic disorders in patients with obesity in the Chinese population.
  • 9 Oct 2025
  • Endokrynologia Polska
Can the treatment of glaucoma cause metabolic acidosis in a person with type 1 diabetes?
  • 9 Oct 2025
  • Endokrynologia Polska
Non-hypoglycemic insulin autoimmune syndrome complicated with T2DM after using lipoic acid.
  • 9 Oct 2025
  • Endokrynologia Polska

FAQs on Endokrynologia Polska